 |
|
Clinical Outcomes of Delayed Clearance of Serum HBsAg in Patients with Chronic HBV Infection
Soon Woo Nam, Jeong Jo Jung, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Se Hyun Cho, Joon Yeol Han, Nam Ik Han, Jin Mo Yang, Young Suk Lee
Korean J Intern Med. 2007;22(2):73-76. Published online 2007 Jun 30 DOI: https://doi.org/10.3904/kjim.2007.22.2.73
|
|
Citations to this article as recorded by
 Establishment of Hepatocellular Carcinoma Risk Prediction Model in Chronic Hepatitis B Patients with Hepatitis B Surface Antigen Seroclearance
Heechul Nam
The Korean Journal of Gastroenterology.2023; 81(2): 104. CrossRef Clinical Consequences of Hepatitis B Surface Antigen Loss in Chronic Hepatitis B Infection: A Systematic Literature Review and Meta-Analysis
Eleonora Morais, Lauren Mason, John Dever, Pam Martin, Jing Voon Chen, Leigh Felton, Stuart Kendrick, Dickens Theodore, Iain A. Gillespie
Gastro Hep Advances.2023; 2(7): 992. CrossRef Systematic review with meta‐analysis: the impact of functional cure on clinical outcomes in patients with chronic hepatitis B
Anusha Vittal, Disha Sharma, Alvin Hu, Nehna A. Majeed, Nancy Terry, Sungyoung Auh, Marc G. Ghany
Alimentary Pharmacology & Therapeutics.2022; 55(1): 8. CrossRef Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients and the Role of Hepatitis B Surface Antigen (HBsAg)
Satinder P. Kaur, Arslan Talat, Hamidreza Karimi-Sari, Andrew Grees, Hao Wei Chen, Daryl T. Y. Lau, Andreea M. Catana
Journal of Clinical Medicine.2022; 11(4): 1126. CrossRef KASL clinical practice guidelines for management of chronic hepatitis B
Clinical and Molecular Hepatology.2022; 28(2): 276. CrossRef Durability of hepatitis B surface antigen seroclearance and subsequent risk for hepatocellular carcinoma: A meta‐analysis
Aixin Song, Xiaoxiao Wang, Junfeng Lu, Yi Jin, Lina Ma, Zhongjie Hu, Yanhong Zheng, Chengli Shen, Xinyue Chen
Journal of Viral Hepatitis.2021; 28(4): 601. CrossRef Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance
Yewan Park, Jeong-Hoon Lee, Dong Hyun Sinn, Jun Yong Park, Minseok Albert Kim, Yoon Jun Kim, Jung-Hwan Yoon, Do Young Kim, Sang Hoon Ahn, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Clinical and Translational Gastroenterology.2021; 12(1): e00290. CrossRef Application of the woodchuck animal model for the treatment of hepatitis B virus-induced liver cancer
Manasa Suresh, Stephan Menne
World Journal of Gastrointestinal Oncology.2021; 13(6): 509. CrossRef In silico functional and structural characterization of hepatitis B virus PreS/S-gene in Iranian patients infected with chronic hepatitis B virus genotype D
Nastaran Khodadad, Seyed Saeed Seyedian, Afagh Moattari, Somayeh Biparva Haghighi, Roya Pirmoradi, Samaneh Abbasi, Manoochehr Makvandi
Heliyon.2020; 6(7): e04332. CrossRef Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis
Yee Hui Yeo, Hsiu J. Ho, Hwai-I Yang, Tai-Chung Tseng, Tetsuya Hosaka, Huy N. Trinh, Min-Sun Kwak, Young Min Park, James Yan Yue Fung, Maria Buti, Manuel Rodríguez, Sombat Treeprasertsuk, Carmen Monica Preda, Teerapat Ungtrakul, Phunchai Charatcharoenwitt
Gastroenterology.2019; 156(3): 635. CrossRef Spontaneous Seroclearance of Hepatitis B Surface Antigen and Risk of Hepatocellular Carcinoma
Ci Song, Jian Zhu, Zijun Ge, Chengxiao Yu, Ting Tian, Hui Wang, Jing Han, Hongbing Shen, Juncheng Dai, Jianquan Lu, Zhibin Hu
Clinical Gastroenterology and Hepatology.2019; 17(6): 1204. CrossRef Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses
Kali Zhou, Caitlin Contag, Evans Whitaker, Norah Terrault
The Lancet Gastroenterology & Hepatology.2019; 4(3): 227. CrossRef KASL clinical practice guidelines for management of chronic hepatitis B
Clinical and Molecular Hepatology.2019; 25(2): 93. CrossRef Natural History and Treatment Indications of Chronic Hepatitis B
Dong Hyun Sinn
The Korean Journal of Gastroenterology.2019; 74(5): 245. CrossRef Single-nucleotide polymorphism of rs7944135 (macrophage-expressed gene 1) is associated with hepatitis B surface antigen seroclearance in chronic hepatitis B infection
Lalu Muhammad Irham, Henry Sung-Ching Wong, Dyah Aryani Perwitasari, Wan-Hsuan Chou, Hwai-I Yang, Wei-Chiao Chang
Medicine.2019; 98(51): e17936. CrossRef Systematic review of risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance
X.‐J. Kuang, R.‐R. Jia, R.‐R. Huo, J.‐J. Yu, J.‐J. Wang, B.‐D. Xiang, L.‐Q. Li, Z. Peng, J.‐H. Zhong
Journal of Viral Hepatitis.2018; 25(9): 1026. CrossRef Identification of novel susceptibility loci associated with hepatitis B surface antigen seroclearance in chronic hepatitis B
Tae Hyung Kim, Eun-Ju Lee, Ji-Hye Choi, Sun Young Yim, Sunwon Lee, Jaewoo Kang, Yoo Ra Lee, Han Ah Lee, Hyuk Soon Choi, Eun Sun Kim, Bora Keum, Yeon Seok Seo, Hyung Joon Yim, Yoon Tae Jeen, Hoon Jai Chun, Hong Sik Lee, Chang Duck Kim, Hyun Goo Woo, Soon H
PLOS ONE.2018; 13(7): e0199094. CrossRef A single-center, single-blind study to evaluate the clinical sensitivity, specificity, and agreement between Elecsys Anti-HBc II and Elecsys Anti-HBc in a Korean population
Taegeun Lee, John Jeongseok Yang, Jinseok Eom, Sohee Kwon, Borae G. Park, Sang-Hyun Hwang, Heung-Bum Oh
Journal of Clinical Virology.2018; 109: 41. CrossRef KASL clinical practice guidelines: management of chronic hepatitis B
Clinical and Molecular Hepatology.2016; 22(1): 18. CrossRef Systematic review with meta‐analysis: development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis B surface antigen seroclearance
F. Liu, X.‐W. Wang, L. Chen, P. Hu, H. Ren, H.‐D. Hu
Alimentary Pharmacology & Therapeutics.2016; 43(12): 1253. CrossRef Spontaneous Clearance of Hepatitis B Surface Antigenemia in a Hemodialysis Patient
Ji Min Jeon, Jong Kun Ha
Korean Journal of Medicine.2014; 87(6): 747. CrossRef Resolving a case of concurrent hepatitis B virus surface antigen (HBsAg) and surface antibody (HBsAb)
Thomas Kampfrath, Saeed A. Jortani, Stanley S. Levinson
Clinica Chimica Acta.2014; 430: 171. CrossRef Serum miR-18a: A Potential Marker for Hepatitis B Virus-Related Hepatocellular Carcinoma Screening
Lihua Li, Zijan Guo, Juanhua Wang, Yong Mao, Qi Gao
Digestive Diseases and Sciences.2012; 57(11): 2910. CrossRef Risk Factors of Cryptogenic Hepatocellular Carcinoma in Patients with Low Body Mass Index or without Metabolic Syndrome
Hwa Young Song, Hyo Keun Lee, June Sung Lee, Jong Yeon Kim, Yun Hyuk Yim, Tae Jun Song, Won Ki Bae, Nam-Hoon Kim, Kyung-Ah Kim
The Korean Journal of Internal Medicine.2012; 27(1): 47. CrossRef KASL Clinical Practice Guidelines: Management of chronic hepatitis B
Clinical and Molecular Hepatology.2012; 18(2): 109. CrossRef Current status of liver diseases in Korea: Hepatitis B
Hee Bok Chae, Jong-Hyun Kim, Ja Kyung Kim, Hyung Joon Yim
The Korean Journal of Hepatology.2009; 15(Suppl 6): S13. CrossRef Clinical outcomes and development of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients
Ji Hoon Kim
The Korean Journal of Hepatology.2009; 15(3): 383. CrossRef Identification of Acute Self-Limited Hepatitis B among Patients Presenting with Hepatitis B Virus-Related Acute Hepatitis: A Hospital-Based Epidemiological and Clinical Study
Y-N Han
Journal of International Medical Research.2009; 37(6): 1952. CrossRef Diagnosis and management of chronic viral hepatitis: Antigens, antibodies and viral genomes
Stéphane Chevaliez, Jean-Michel Pawlotsky
Best Practice & Research Clinical Gastroenterology.2008; 22(6): 1031. CrossRef Elevated Expression of the miR-17–92 Polycistron and miR-21 in Hepadnavirus-Associated Hepatocellular Carcinoma Contributes to the Malignant Phenotype
Erin Connolly, Margherita Melegari, Pablo Landgraf, Tatyana Tchaikovskaya, Bud C. Tennant, Betty L. Slagle, Leslie E. Rogler, Mihaela Zavolan, Thomas Tuschl, Charles E. Rogler
The American Journal of Pathology.2008; 173(3): 856. CrossRef
|